1.
Diller L et al.: Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 2009;27:2339-2355.
2.
Trachtenberg BH et al.: Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol 2011;32:342-353.
3.
Schellong G et al.: Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence - an observational study with up to 33-year follow-up. Dtsch Arztebl Int 2014;111:3-9.
4.
Frobisher C et al.: Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up. Br J Cancer 2017;117:1723-1731.
5.
Gebauer J et al.: [Late effects following childhood cancer treatment: a special challenge for transition medicine]. Internist (Berl) 2018;59:1157-1162.
6.
Gebauer J et al.: Multidisciplinary late effects clinics for childhood cancer survivors in Germany - a two-center study. Oncol Res Treat 2018;41:430-436.
7.
Kaatsch P et al.: Annual Report 2017 (1980-2016). Mainz, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz, 2018.
8.
www.onkopedia.com/de/onkopedia/guidelines/heranwachsende-und-junge-erwachsene-aya-adolescents-and-young-adults.
9.
Gibson TM et al.: Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 2018;19:1590-1601.
10.
Hudson MM et al.: Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013;309:2371-2381.
11.
Oeffinger KC et al.: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582.
12.
https://innovationsfonds.g-ba.de/projekte/neue-versorgungsformen/das-care-for-caya-programm-ganzheitliches-praeventionsprogramm-fuer-junge-patienten-nach-ueberstandener-krebserkrankung-im-kindes-jugend-und-jungen-erwachsenenalter-cayas.112.
13.
Nass SJ et al.: Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist 2015;20:186-195.
14.
Veneroni L et al.: Creating beauty: The experience of a fashion collection prepared by adolescent patients at a pediatric oncology unit. Tumori 2015;101:626-630.
15.
Ferrari A et al.: Searching for happiness. Clin Oncol 2017;35:2209-2212.
16.
Ferrari A et al.: Clouds of oxygen: Adolescents with cancer tell their story in music. J Clin Oncol 2015;33:218-221.
17.
Signoroni S et al.: «Summer is you»: Adolescents and young adults with cancer sing about their desire for summer. Pediatr Blood Cancer 2019;66:e27630.
18.
https://fivewishes.org/docs/default-source/Samples/vmc-sample.pdf?sfvrsn=4.
19.
Wiener L et al.: How I wish to be remembered: The use of an advance care planning document in adolescent and young adult populations. J Palliat Med 2008;11:1309-1313.
20.
Wiener I et al.: Allowing adolescents and young adults to plan their end-of-life care. Pediatrics 2012;130:897-905.
21.
http://jqmobile.onkopedia.com/de/ayapedia.
22.
https://junge-erwachsene-mit-krebs.de/jung-und-krebs/treffpunkte/.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2019
You do not currently have access to this content.